Lung cancer's real adjuvant EGFR targeted therapy questions

Lancet Oncol. 2018 Jan;19(1):15-17. doi: 10.1016/S1470-2045(17)30875-6. Epub 2017 Nov 21.

Authors

Terry L Ng¹, D Ross Camidge²

Affiliations

¹ Division of Medical Oncology, University of Colorado Cancer Center, Aurora, CO 80045, USA.
² Division of Medical Oncology, University of Colorado Cancer Center, Aurora, CO 80045, USA. Electronic address: [email protected].

PMID: 29174309
DOI: 10.1016/S1470-2045(17)30875-6

No abstract available

Publication types

Comment

MeSH terms

Adjuvants, Immunologic
ErbB Receptors*
Humans
Lung Neoplasms*
Molecular Targeted Therapy
Neoplasms

Substances

Adjuvants, Immunologic
EGFR protein, human
ErbB Receptors